The DOI matches its Crossref record; 52 of the 52 references it cites were found in a registry or an index.
Microbubbles in combination with focused ultrasound for the delivery of quercetin-modified sulfur nanoparticles through the blood brain barrier into the brain parenchyma and relief of endoplasmic reticulum stress to treat Alzheimer's disease
Abstract
The delivery of drugs across the blood–brain barrier (BBB) effectively and safely is one of the major challenges in the treatment of neurodegenerative diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In combination with ultrasound, this system could accumulate in the brain and promote drug delivery because of the transient opening of the BBB.”
From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [224]
In the citing paper
“Qc@SNPs-MB effectively treated Alzheimer’s disease by protecting nerve cells and reducing endoplasmic reticulum stress which comes from oxidative stress, inflammatory response, calcium homeostasis imbalance, and neuronal apoptosis.”
From The blood–brain barrier: Structure, regulation and drug delivery (2023) · cites this paper as [224]
Citations
Cites
Endoplasmic reticulum stress: cell life and death decisions
Xu, C. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26373 · Cited by 2,291
From endoplasmic-reticulum stress to the inflammatory response
Zhang, K., & Kaufman, R. J. (2008) · Nature · doi:10.1038/nature07203 · Cited by 2,010
Redox- and non-redox-metal-induced formation of free radicals and their role in human disease
Valko, M., Jomová, K., Rhodes, C. J., Kuča, K., & Musílek, K. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1579-5 · Cited by 1,062
Overcoming the Blood–Brain Barrier: The Role of Nanomaterials in Treating Neurological Diseases
Furtado, D., Björnmalm, M., Ayton, S., Bush, A. I., Kempe, K., & Caruso, F. (2018) · Advanced Materials · doi:10.1002/adma.201801362 · Cited by 708
Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases
Hetz, C., & Mollereau, B. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3689 · Cited by 684
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 683
Alzheimer's Disease: From Pathology to Therapeutic Approaches
Jakob‐Roetne, R., & Jacobsen, H. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200802808 · Cited by 626
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M. H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 612
Ai, X., Ho, C. J. H., Aw, J., Attia, A. B. E., Mu, J., Wang, Y., Wang, X., Wang, Y., Liu, X., Chen, H., et al. (2016) · Nature Communications · doi:10.1038/ncomms10432 · Cited by 432
Self-citationRecent advances in nanomaterial-based synergistic combination cancer immunotherapy
Sang, W., Zhang, Z., Dai, Y., & Chen, X. S. (2019) · Chemical Society Reviews · doi:10.1039/c8cs00896e · Cited by 409
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- Kuehn, 2018, J. Am. Med. Assoc., 320, 1851
Cited by
Sorted by citations
Items 101–123 of 123
Nelson, K. M., Donzanti, M. J., Mhatre, O., & Gleghorn, J. P. (2026) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-102723-021307 · Cited by 3
Ma, C., Song, S., Dai, J., & Shen, H. (2026) · Journal of Functional Biomaterials · doi:10.3390/jfb17030113 · Cited by 1
Progress and challenges in drug delivery for the treatment of Alzheimer’s disease
Haghighi, F. H., Xie, J., Ebert, E., & Siahaan, T. J. (2026) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2026.2663114 · Cited by 1
Nanoparticles that target nonamyloid and nontau pathways in Alzheimer’s disease
Alavian, F., & Hajimohammadi, A. (2026) · Discover Nano · doi:10.1186/s11671-026-04747-8 · Cited by 1
Jamil, D. U., Umar, M. I., & Fasanmade, A. A. (2023) · KIU Journal of Health Sciences · doi:10.59568/kjhs-2023-3-1-04 · Cited by 1
Phytonanoparticles for the treatment of Alzheimer’s disease: A review
Chellammal, H. S. J., Singh, G. K. S., Kumar, S. S., & Ramachandran, D. (2022) · Journal of Phytonanotechnology and Pharmaceutical Sciences · doi:10.54085/jpps.2022.2.3.1
On minimal focal distance of a focused ultrasound probe for neuromodulation
Chu, Y.-C., Ho, C.-Y., Chuo, Y., Wu, H.-H., & Wang, J. (2023) · JASA Express Letters · doi:10.1121/10.0017106
Ultrasound-responsive nanocarriers for drug delivery
Shah, M. R., Jabri, T., & Khalid, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22389-1.00008-0
Applications of Nanotechnology in Degenerative Disorders of the Brain
Lopes, D. H. J., Sisi, F. Y., Mehrabian, A., Davoudkhani, M., Noroozıan, M., Khawaja, A. M., & Heiss, J. D. (2024) · Springer eBooks · doi:10.1007/978-3-030-80662-0_30
Hsueh, S.-Y., Lu, Y., Lim, J., Chu, Y.-C., Lin, P., Chan, Y., Wu, Y., Wu, C.-C., & Wang, J. (2025) · Hearing Research · doi:10.1016/j.heares.2025.109379
A Glimpse of the Role of Olfactory Tubercle in Neuropsychiatric Disorders
Liu, J., Zhong, Y., Shi, H., Song, Z.-W., Tan, R., Wang, M., Yang, J., Wang, H., & Zhang, Y. F. (2025) · Flavour and Fragrance Journal · doi:10.1002/ffj.70010
Self-citationWang, C., Cai, X., Wang, R., Zhai, S., Zhang, Y., Hu, W., Zhang, Y., & Wang, D. (2020) · Figshare · doi:10.6084/m9.figshare.13108606
Saladino, G. M., Martinez, P. J., Wang, J., Roudi, R., Annio, G., Airan, R. D., & Daldrup-Link, H. E. (2026) · Materials Today Bio · doi:10.1016/j.mtbio.2026.103280 · Cited by 1
Application of Focused Ultrasound in Alzheimer’s Disease: A Bibliometric Analysis
Yu, J., Chen, Y., Bai, J., Zeng, J., Zhao, J., & Fan, Y. (2026) · Journal of Craniofacial Surgery · doi:10.1097/scs.0000000000012990
Nanotherapeutics targeting neuroinflammation
Chaulagain, B., Tagoe, B., Gothwal, A., Mahanta, A. K., Muolokwu, C. E., Lamsal, B., & Singh, J. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-33623-2.00013-1
Jiang, Z., Zhang, J., Zhang, X., Xie, C., Chen, X., Ma, G., Lu, X., Ai, Y., & Jia, T. (2026) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-026-05599-w
Self-citationWang, T., Ding, X., Zhang, C., Zhang, H., Mu, Y., & Zhang, T. (2026) · Biochemical Pharmacology · doi:10.1016/j.bcp.2026.118213
Jarrar, B. M., Almansour, M. I., Al-Doaiss, A. A., Jarrar, Q., & Sewelam, A. (2026) · Research Square · doi:10.21203/rs.3.rs-9773651/v1
Quercetin for brain diseases: Preclinical evidence and therapeutic potentials
Fang, X.-L., Chen, H., Xu, Z.-Q., Xu, J., Yin, X.-Y., Yang, H.-Y., Wang, Q., & Huang, S. (2026) · Journal of Chinese Integrative Medicine · doi:10.1016/j.joim.2026.07.009
Zhou, H., Wang, S., Nuerboli, S., Guo, X., Luo, L., & You, J. (2026) · Nanoscale · doi:10.1039/d6nr01043a
Self-citationDigital twins and nanomedicine: Predictive modelling for clinical translation
Chowdhury, S., Sarkar, S., & Das, A. (2026) · Next Nanotechnology · doi:10.1016/j.nxnano.2026.100688 · Cited by 1
Advanced Materials for Biologics Delivery to Brain Tumors
Feng, Y., Cao, Y., Kavallaris, M., Janjua, T. I., & Popat, A. (2026) · Advanced Materials · doi:10.1002/adma.74760
Begum, M. Y., Rajkumar, M., Govindaraj, P., Velmani, S., Rajkumar, P., Sudha, P. N., Hamod, M. A., & Alotaibi, H. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-06188-x
Metadata
- Authors
- Liu, Y., Gong, Y., Xie, W., Huang, A., Yuan, X., Zhou, H., Zhu, X., Chen, X., Liu, J., Liu, J., & Qin, X.
- Affiliations
- Jinan University (CN)
- College of Pharmacy
- Corresponding author
- Liu, Jie
- Venue
- Nanoscale
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2020
- Volume
- 12
- Issue
- 11
- Pages
- 6498-6511
- ISSN
- 2040-3364 (ISSN-L)
- 2040-3372
- OpenAlex
- W3003203987
- Cited by
- 123
- References
- 52
- Citations by year
- 2026: 18 · 2025: 20 · 2024: 22 · 2023: 15 · 2022: 25 · 2021: 16 · 2020: 7
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nanoscale (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81803027, 21877051, 21701034)
- Natural Science Foundation of Guangdong Province (2018A030310628)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › Ultrasound and Hyperthermia Applications
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- microbubbles, focused ultrasound, blood-brain barrier, sonoporation, quercetin, sulfur nanoparticles, Alzheimer's disease, endoplasmic reticulum stress, brain drug delivery, neuroprotection, oxidative stress, memory impairment, neuroinflammation, calcium homeostasis
- MeSH terms
- Ultrasonic Waves, Alzheimer Disease, Animals, Blood-Brain Barrier, Cell Line, Disease Models, Animal, Humans, Quercetin, Drug Delivery Systems, Microbubbles, Mice, Nanoparticles, Endoplasmic Reticulum Stress
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review